UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Japanese Clinical Practice Guideline for Diabetes 2019

Diabetology international, 2020-07, Vol.11 (3), p.165-223

2020

Volltextzugriff (PDF)

Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications

Antioxidants & redox signaling, 2007-03, Vol.9 (3), p.343-353

2007

Volltextzugriff (PDF)

Japanese Clinical Practice Guideline for Diabetes 2019

Journal of diabetes investigation, 2020-07, Vol.11 (4), p.1020-1076

2020

Volltextzugriff (PDF)

Introduction of Our New Guideline, "Japanese Clinical Practice Guideline for Diabetes 2019"

Journal of the Japan Diabetes Society, 2020/10/30, Vol.63(10), pp.674-677

Araki, Eiichi

2020

Volltextzugriff (PDF)

New classification and diagnostic criteria for insulin resistance syndrome

Endocrine Journal, 2022, Vol.69(2), pp.107-113

2022

Volltextzugriff (PDF)

FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism

Nature communications, 2019-04, Vol.10 (1), p.1582-1582, Article 1582

2019

Volltextzugriff (PDF)

Brown adipocyte-derived exosomal miR-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genes

Biochemical and biophysical research communications, 2020-09, Vol.530 (3), p.500-507

2020

Volltextzugriff (PDF)

Updates of incretin‐related drugs for the treatment of type 2 diabetes

Journal of diabetes investigation, 2023-02, Vol.14 (2), p.189-192

2023

Volltextzugriff (PDF)

Japanese Clinical Practice Guideline for Diabetes 2016

Journal of diabetes investigation, 2018-05, Vol.9 (3), p.657-697

2018

Volltextzugriff (PDF)

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

Journal of Atherosclerosis and Thrombosis, 2018/06/01, Vol.25(6), pp.521-538

2018

Volltextzugriff (PDF)

Hyperglycemia Induces Cellular Hypoxia through Production of Mitochondrial ROS Followed by Suppression of Aquaporin-1

PloS one, 2016-07, Vol.11 (7), p.e0158619-e0158619

2016

Volltextzugriff (PDF)

Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: Report of the Committee on Causes of Death in Diabetes Mellitus

Journal of diabetes investigation, 2017-05, Vol.8 (3), p.397-410

2017

Volltextzugriff (PDF)

Hypoglycemia Induces Mitochondrial Reactive Oxygen Species Production Through Increased Fatty Acid Oxidation and Promotes Retinal Vascular Permeability in Diabetic Mice

Antioxidants & redox signaling, 2021-06, Vol.34 (16), p.1245-1259

2021

Volltextzugriff (PDF)

LSD1 defines the fiber type-selective responsiveness to environmental stress in skeletal muscle

eLife, 2023-01, Vol.12

2023

Volltextzugriff (PDF)

Japanese Clinical Practice Guideline for Diabetes 2016

Diabetology international, 2018-02, Vol.9 (1), p.1-45

2018

Volltextzugriff (PDF)

AMPK and cell proliferation â AMPK as a therapeutic target for atherosclerosis and cancer

The Journal of physiology, 2006-07, Vol.574 (1), p.63-71

2006

Volltextzugriff (PDF)

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment

International journal of molecular sciences, 2019-02, Vol.20 (3), p.706

2019

Volltextzugriff (PDF)

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis

Journal of diabetes investigation, 2022-12, Vol.13 (12), p.1971-1980

2022

Volltextzugriff (PDF)

SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice

Nature communications, 2022-12, Vol.13 (1), p.7439-7439, Article 7439

2022

Volltextzugriff (PDF)

Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes

Journal of diabetes investigation, 2022-12, Vol.13 (12), p.1958-1960

2022

Volltextzugriff (PDF)

Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate

Journal of Atherosclerosis and Thrombosis, 2021/09/01, Vol.28(9), pp.974-996

2021

Volltextzugriff (PDF)

Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination

International journal of molecular sciences, 2019-11, Vol.20 (22), p.5537

2019

Volltextzugriff (PDF)

SIRT7 Controls Hepatic Lipid Metabolism by Regulating the Ubiquitin-Proteasome Pathway

Cell metabolism, 2014-04, Vol.19 (4), p.712-721

2014

Volltextzugriff (PDF)

Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　― A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society

Circulation Journal, 2020/12/25, Vol.85(1), pp.82-125

2020

Volltextzugriff (PDF)

Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials

Cardiovascular diabetology, 2021-05, Vol.20 (1), p.96-96, Article 96

2021

Volltextzugriff (PDF)

1 – 25 von 586

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(425)
Mit Volltextzugriff
(496)

Publikationsform

Sprache

Englisch
(457)
Japanisch
(137)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Japanese Clinical Practice Guideline for Diabetes 2019

Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications

Japanese Clinical Practice Guideline for Diabetes 2019

Introduction of Our New Guideline, "Japanese Clinical Practice Guideline for Diabetes 2019"

New classification and diagnostic criteria for insulin resistance syndrome

FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism

Brown adipocyte-derived exosomal miR-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genes

Updates of incretin‐related drugs for the treatment of type 2 diabetes

Japanese Clinical Practice Guideline for Diabetes 2016

Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

Hyperglycemia Induces Cellular Hypoxia through Production of Mitochondrial ROS Followed by Suppression of Aquaporin-1

Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001–2010: Report of the Committee on Causes of Death in Diabetes Mellitus

Hypoglycemia Induces Mitochondrial Reactive Oxygen Species Production Through Increased Fatty Acid Oxidation and Promotes Retinal Vascular Permeability in Diabetic Mice

LSD1 defines the fiber type-selective responsiveness to environmental stress in skeletal muscle

Japanese Clinical Practice Guideline for Diabetes 2016

AMPK and cell proliferation â AMPK as a therapeutic target for atherosclerosis and cancer

Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis

SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice

Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes

Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPARα Modulator, Pemafibrate

Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination

SIRT7 Controls Hepatic Lipid Metabolism by Regulating the Ubiquitin-Proteasome Pathway

Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　― A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society

Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials

Suchergebnisse filtern